Arthritic Therapeutic Market Poised to Hit $91.72 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Arthritic Therapeutic Market Size Growth Forecast: What to Expect by 2025?
Over the last few years, the market size for arthritis therapeutics has seen robust growth. It's projected to increase from $68.1 billion in 2024 to $72.44 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth throughout the historical period include a rise in the number of diagnosed patients, heightened awareness regarding symptoms, escalating obesity rates, enhanced diagnostic abilities, and better treatment results.

How Will the Arthritic Therapeutic Market Size Evolve and Grow by 2029?
Expectations are high for the arthritic therapeutic market size, which is predicted to experience robust growth in the upcoming years. By 2029, it is forecasted to reach $91.72 billion, with a compound annual growth rate (CAGR) of 6.1%. The predicted growth during the forecast period is due in part to advancements in healthcare infrastructure, government-led initiatives, favorable regulatory frameworks, a spotlight on personalized medicine, and a move towards patient-oriented healthcare practices. Other key trends to watch during this forecast period include a focus on biosimilars, a shift towards biologics, increased accessibility of biosimilars, a preference for the parenteral route, and the rise of online pharmacies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/arthritic-therapeutic-global-market-report

What Drivers Are Propelling the Growth of Arthritic Therapeutic Market Forward?
The escalation in the prevalence of arthritis is projected to fuel the expansion of the arthritic therapeutic market in the near future. Arthritis is an umbrella term for over 100 conditions primarily typified by joint discomfort and mild to severe inflammation. Factors fueling the surge in arthritis cases include aging demographics, rising obesity incidents, and lifestyle habits that add to joint pressure and inflammation triggers. Arthritis treatments aim to ease symptoms, minimize inflammation, and optimize joint function, thereby improving the overall standard of living for those affected. For instance, a report released in June 2024 by the Australian Institute of Health and Welfare, an Australia-based government body, stated that around 514,000 individuals (2.0% of the population) were diagnosed with rheumatoid arthritis in 2022. Rheumatoid arthritis accounted for 2.0% of the total disease onus and was responsible for 16% of the entire burden for all musculoskeletal ailments in 2023. Consequently, the escalating arthritis prevalence is propelling the expansion of the arthritic therapeutic market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19297&type=smp

Which Emerging Trends Are Transforming the Arthritic Therapeutic Market in 2025?
The primary players in the arthritis therapeutic market are concentrating on the creation of innovative approaches such as biosimilar monoclonal antibody-based therapies to increase the efficacy of treatment and lessen expenses. These therapies aim to closely emulate the potency of original monoclonal antibodies, offering similar medical advantages potentially at a lower price. For example, Bio-Thera Solutions Ltd., a biopharmaceutical firm based in China, rolled out TOFIDENCE, a biosimilar monoclonal antibody formulation which is a version of ACTEMRA, in May 2024. It's designed as a biosimilar to ACTEMRA and approved for treatment of moderately to severely active rheumatoid arthritis, systemic juvenile idiopathic arthritis, and polyarticular juvenile idiopathic arthritis.

What Are the Key Segments in the Arthritic Therapeutic Market?
The arthritic therapeuticmarket covered in this report is segmented -

1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab
2) By Interleukin Inhibitors: Interleukin-6 (IL-6) Inhibitors, Interleukin-1 (IL-1) Inhibitors, Interleukin-17 (IL-17) Inhibitors, Interleukin-23 (IL-23) Inhibitors
3) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam
4) By Corticosteroids: Prednisone, Methylprednisolone, Hydrocortisone, Dexamethasone
5) By Xanthine Oxidase Inhibitors: Allopurinol, Febuxostat
6) By Other Drug Classes: Disease-Modifying Antirheumatic Drugs (DMARDs), Janus Kinase (JAK) Inhibitors, Biologic DMARDs, Topical Analgesics, Opioid Pain Medications

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19297&type=smp

Who Are the Key Players Shaping the Arthritic Therapeutic Market's Competitive Landscape?
Major companies operating in the arthritic therapeutic market are Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH

What Geographic Markets Are Powering Growth in the Arthritic Therapeutic Market?
North America was the largest region in the arthritic therapeutic market in 2024. The regions covered in the arthritic therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19297

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.